Neuroscience
Magnetic Resonance Imaging
100%
Bipolar Disorder
56%
Magnetic Resonance Imaging
47%
Cognitive Disorders
45%
Positron Emission Tomography
34%
Cognitive Function
30%
Hippocampus
29%
Depression
28%
Choline
23%
Encephalopathy
22%
Positron Emission Tomography
19%
Traumatic Brain Injury
18%
Neurotrauma
18%
Bipolar I Disorder
18%
Bevacizumab
18%
Meta-Analysis
18%
Chemical Shift Imaging
18%
Multiple Sclerosis
18%
Diffusion Tensor Imaging
18%
Fractional Anisotropy
18%
Atrial Fibrillation
18%
Nuclear Magnetic Resonance Spectroscopy
17%
N-Acetylaspartic Acid
16%
Late Life Depression
14%
Relapsing Remitting Multiple Sclerosis
13%
Single-Photon Emission Computed Tomography
11%
Gray Matter
11%
Imaging Technique
11%
Microglia
10%
Longitudinal Study
10%
Functional Magnetic Resonance Imaging
9%
Near Infrared Spectroscopy
9%
Aneurysm
9%
Brain Ischemia
9%
Sjoegren Larsson Syndrome
9%
Migraine
9%
Mild Cognitive Impairment
9%
DNA Template
9%
Angiography
9%
Cognitive Neuroscience
9%
Behavioral Neuroscience
9%
Subarachnoid Hemorrhage
9%
Apolipoprotein E
9%
Dementia Praecox
9%
Brain Imaging
9%
Delirium
9%
Vasomotor
9%
Circle of Willis
9%
Aspartic Acid
7%
Glutamic Acid
7%
Keyphrases
White Matter Lesions
94%
Cerebral White Matter Lesions
84%
Elderly People
30%
Periventricular White Matter Injury
24%
Magnetic Resonance Imaging
24%
Depressive Symptoms
23%
Magnetic Resonance Imaging Study
21%
Population-based
20%
Bipolar Disorder
18%
Chemical Shift Imaging
18%
Human Brain
18%
Rotterdam
18%
Choline
18%
Recurrent Glioblastoma
18%
N-acetylaspartate
16%
Brain Atrophy
13%
Functional Outcome
12%
Blood Pressure Level
12%
Blood Pressure
12%
Lipid Signaling
11%
1H Chemical Shifts
11%
Cerebral Atrophy
11%
Atrial Fibrillation
11%
Diastolic Blood Pressure
11%
Microhemorrhage
11%
Cognitive Consequences
10%
Confidence Interval
9%
Bipartition
9%
Bipartite Atlas
9%
Rate of Cognitive Decline
9%
Enhanced Magnetic Resonance Imaging
9%
Mangafodipir
9%
Dual Phase
9%
Resonant Phase
9%
Multiple Sclerosis
9%
Disability Progression
9%
Examination Tools
9%
Progression Rate
9%
T2 Lesions
9%
Cognitive Goal
9%
Positron Emission Tomography Study
9%
University Hospital
9%
Fresolimumab
9%
Lithium
9%
Neurologist
9%
Preeclampsia
9%
Hippocampus
9%
Neuroinflammation
9%
Airway Inflammation
9%
Hemangioblastoma
9%
Medicine and Dentistry
White Matter Lesion
99%
Magnetic Resonance Imaging
64%
Positron Emission Tomography
31%
Eclampsia
30%
Brain Ischemia
28%
Radiology
28%
Eclampsia and Preeclampsia
19%
Cognitive Defect
19%
Percutaneous Thrombectomy
18%
Nuclear Magnetic Resonance
18%
Positron Emission Tomography
15%
Magnetic Resonance Angiography
15%
Isotopes of Calcium
13%
Metabolite
13%
Depression
12%
Pre-Eclampsia
12%
Posterior Reversible Encephalopathy Syndrome
12%
Coronary Artery Disease
11%
Atrial Fibrillation
11%
Glioblastoma
10%
Computer Assisted Tomography
10%
Blood Pressure
10%
Pathophysiology
9%
Asthma
9%
Respiratory Tract Inflammation
9%
Vitamin D
9%
Systematic Review
9%
Coronary Artery
9%
Ammonia N 13
9%
Quality of Life
9%
Meta-Analysis
9%
Transforming Growth Factor Beta Antibody
9%
Fresolimumab
9%
Chemical Shift Imaging
9%
Coronary Computed Tomography Angiography
9%
Allergic Asthma
9%
Obstetrics
9%
Cognition
9%
near Infrared Spectroscopy
9%
Carotid Atherosclerosis
9%
Diagnosis
9%
Thrombolytic Drug
9%
Choline
9%
N Acetylaspartic Acid
9%
Levetiracetam
9%
Heart Muscle Perfusion
9%
Mangafodipir
9%
Ischemia
9%
Spiral Computed Tomography
9%
Ganglioglioma
9%
